Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03399500 · ClinicalTrials.gov registry record · Phase 3
Homeless Care Management App
A Phase 3 study of Substance Use Disorders and Health Behavior, sponsored by University of Oklahoma.
- Completed
- Registry status
- Phase 3
- Development phase
- 403
- Enrollment target
- 2
- Study locations
NCT03399500 is a Phase 3 study of Substance Use Disorders and Health Behavior that has completed, run by University of Oklahoma. The registered enrollment target is 403 participants, below the 496-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (19% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03399500, a Phase 3 study of Substance Use Disorders and Health Behavior, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 403 participants
- Enrollment target
- 2
- Study locations
Study Summary
There is a significant revolving door of incarceration among homeless adults, a population with substantial health disparities. Homeless adults who receive the professional coordination of individualized care (i.e., case management) during the period following their release from jail experience fewer mental health and substance use problems, are more likely to obtain stable housing, and are less likely to be re-incarcerated. The proposed study will use mobile technology to address these barriers and fill gaps in the understanding of the causes of the revolving door of homeless incarceration. This research represents a step toward integrated service connection and healthcare service provision for one of the most underserved, high need, and understudied populations in the United States. Smart phone apps that increase the use of available healthcare services and identify predictors of key outcomes (e.g., homelessness, re-arrest, medication compliance) could be used to reach hard to reach populations with histories of significant and persistent health disparities (e.g., homeless adults).
Conditions Studied
Interventions
- BEHAVIORAL In-Person Case Management at Homeless Recovery Program
- BEHAVIORAL Unlimited Smartphone
- BEHAVIORAL Smartphone Based Case Management (SPCM) app
Study Locations (2)
Oklahoma
- University of Oklahoma Health Sciences Center - OTRC - Oklahoma City
Texas
- UTHealth School of Public Health - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 403 participants |
| Start Date | 2018-04-27 |
| Est. Completion | 2023-11-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03399500
The ClinicalTrials.gov registry entry for NCT03399500 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 403 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 496-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (19% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 3 interventions - of which In-Person Case Management at Homeless Recovery Program is the first listed.
NCT03399500 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Oklahoma, Texas.
Frequently Asked Questions
What is clinical trial NCT03399500 about?
NCT03399500 is a clinical study titled "Homeless Care Management App". There is a significant revolving door of incarceration among homeless adults, a population with substantial health disparities. Homeless adults who receive the professional coordination of individualized care (i.e., case management) during the period following their release from jail experience fewe...
What is the current status of trial NCT03399500?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 403 participants. The study started on 2018-04-27. Estimated completion is 2023-11-14.
What conditions does trial NCT03399500 study?
This clinical trial studies the following conditions: Substance Use Disorders, Health Behavior, Adherence, Patient, Mental Health Impairment.
What interventions are being tested in trial NCT03399500?
The interventions under investigation include: In-Person Case Management at Homeless Recovery Program (BEHAVIORAL), Unlimited Smartphone (BEHAVIORAL), Smartphone Based Case Management (SPCM) app (BEHAVIORAL).
Who is sponsoring clinical trial NCT03399500?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03399500 being conducted?
This trial has 2 study locations across Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)
COMPLETED · Phase 3
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.